...
首页> 外文期刊>Immunobiology: Zeitschrift fur Immunitatsforschung >Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients
【24h】

Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients

机译:溃疡性结肠炎患者固有层固有核细胞增加可溶性TLR2的产量

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Toll-like receptor 2 (TLR2) is a type I pattern recognition receptor that has been shown to participate in intestinal homeostasis. Its increased expression in the lamina propria has been associated with the pathogenesis in inflammatory bowel disease (IBD), such as ulcerative colitis (UC) and Crohn's disease (CD). Recently, soluble TLR2 (sTLR2) variants have been shown to counteract inflammatory responses driven by the cognate receptor. Despite the evident roles of TLR2 in intestinal immunity, no study has elucidated the production and cellular source of sTLR2 in IBD. Furthermore, an increase in the population of activated macrophages expressing TLR2 that infiltrates the intestine in IBD has been reported. We aimed first to assess the production of the sTLR2 by UC and CD organ culture biopsies and lamina propria mononuclear cells (LPMCs) as well as the levels of sTLR2 in serum, and then characterize the cell population from lamina propria producing the soluble protein.Mucosa explants, LPMCs and serum were obtained from UC, CD patients and control subjects. The level of sTLR2 was higher in conditioned media from organ culture biopsies and LPMCs from UC patients in comparison to CD and controls. Moreover, an inverse correlation between the content of intestinal and serum sTLR2 levels was observed in UC patients. Additionally, when characterizing the cellular source of the increased sTLR2 by LPMCs from UC patients, an increase in TLR2 +/CD33 + cell population was found. Also, these cells expressed CX3CR1, which was related to the increased levels of intestinal FKN in UC patients, suggesting that a higher proportion of TLR2 + mononuclear cells infiltrate the lamina propria. The increased production of sTLR2 suggests that a differential regulating factor of the innate immune system is present in the intestinal mucosa of UC patients.
机译:Toll样受体2(TLR2)是一种I型模式识别受体,已被证明参与肠道动态平衡。其在固有层中的表达增加与炎性肠病(IBD),例如溃疡性结肠炎(UC)和克罗恩氏病(CD)的发病机理有关。最近,可溶性TLR2(sTLR2)变体已显示出可抵消由同源受体驱动的炎症反应。尽管TLR2在肠道免疫中具有明显的作用,但尚无研究阐明IBD中sTLR2的产生和细胞来源。此外,已经报道了在IBD中渗透入肠道的表达TLR2的活化巨噬细胞的数量增加。我们的目标是首先评估UC和CD器官培养活检和固有层单核细胞(LPMC)产生的sTLR2以及血清中sTLR2的水平,然后表征产生可溶性蛋白的固有层的细胞群。从UC,CD患者和对照受试者获得外植体,LPMC和血清。与CD和对照组相比,器官培养活检和UC患者的LPMC产生的条件培养基中sTLR2的水平更高。此外,在UC患者中观察到肠内含量与血清sTLR2水平成反比。另外,当表征来自UC患者的LPMCs增加的sTLR2的细胞来源时,发现TLR2 + / CD33 +细胞群增加。而且,这些细胞表达CX3CR1,这与UC患者肠道FKN的水平升高有关,表明较高比例的TLR2 +单核细胞浸润固有层。 sTLR2产量的增加表明,UC患者的肠粘膜中存在先天免疫系统的差异调节因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号